Melatonin shows promising but uncertain benefits for sleep disruptions in patients with malignancies, however, the evidence should be interpreted cautiously because of substantial clinical and statistical heterogeneity, limited sample sizes, short intervention durations, and predominantly subjective sleep measures.
Mohammad mehdi Abbasi, S. Pasha, F. Khosravi et al.· Current Reviews in Clinical...· 0 citations
Challenges related to cost‐effective scalability, accessibility of advanced diagnostics, and optimization of therapeutic systems continue to limit clinical translation and future research must prioritize multidisciplinary collaborations to accelerate drug development, enhance diagnostic capabilities, and expand nanotec...
Silvi Gautam, Jahanvi Saini, S. Pasha et al.· Pulmonary Medicine· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.